Successful Treatment of Rhino-Orbital Mucormycosis with Posaconazole and Hyperbaric Oxygen Therapy

Mucormycosis is a rare, but invasive infection caused by ubiquitous molds. Amphotericin B and surgery have been known to help improve the outcome. Sporadic case reports support the use of posaconazole in adults. We report a toddler with acute lymphoblastic leukemia who acquired rhino-orbital mucormycosis caused by Rhizopus species at the end of induction chemotherapy. She was successfully treated with multiple surgical debridements, amphotericin B, posaconazole and hyperbaric oxygen therapy. In conclusion, mucormycosis is a serious infection that requires aggressive surgical and medical therapy. To the best of our knowledge the use of posaconazole combined with hyperbaric oxygen therapy has not been reported in a toddler with leukemia and invasive Rhizopus sp. infection. This approach was found to be safe and effective in our patient.

[1]  T. Zaoutis,et al.  Trends in zygomycosis in children , 2012, Mycoses.

[2]  T. Walsh,et al.  Rhino-Orbital-Cerebral Mucormycosis , 2012, Current Infectious Disease Reports.

[3]  D. Enoch,et al.  Posaconazole for the treatment of mucormycosis. , 2011, International journal of antimicrobial agents.

[4]  M. Wagenmann,et al.  Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis. , 2010, Auris, nasus, larynx.

[5]  A. Attarbaschi,et al.  Posaconazole salvage treatment in paediatric patients: a multicentre survey , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  A. Groll,et al.  Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  T. Walsh,et al.  Zygomycosis in Children: A Systematic Review and Analysis of Reported Cases , 2007, The Pediatric infectious disease journal.

[8]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Brad Spellberg,et al.  Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management , 2005, Clinical Microbiology Reviews.